# Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis

> **NCT01650181** · PHASE4 · COMPLETED · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 50 (actual)

## Conditions studied

- Liver Disease

## Interventions

- **DRUG:** Metformin
- **DIETARY_SUPPLEMENT:** Siliphos+ Selenium - Methionine + Alpha Lipoic Acid
- **DIETARY_SUPPLEMENT:** Siliphos+ Selenium - Methionine + Alpha Lipoic Acid
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01650181
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01650181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01650181, "Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01650181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*